Immunologix Laboratories
Immunologix Laboratories is a science-based GLP and GCP compliant immunoassay laboratory focused on ligand binding based bioanalysis and biomarkers. Since 2012, it has been dedicated to providing scientific partnerships that deliver high-quality, customized bioanalytical and biomarker strategies to support drug development. The company emphasizes a science-first approach, strategic partnerships, and innovative solutions across various stages of drug development.
Industries
Nr. of Employees
medium (51-250)
Immunologix Laboratories
Tampa, Florida, United States, North America
Products
Ready-to-use biomarker assay panels (single-analyte and multiplex)
Validated off-the-shelf biomarker assays and multiplex panels for rapid deployment in clinical and research studies, delivered with analytical performance data aligned to specific contexts of use.
Ready-to-use biomarker assay panels (single-analyte and multiplex)
Validated off-the-shelf biomarker assays and multiplex panels for rapid deployment in clinical and research studies, delivered with analytical performance data aligned to specific contexts of use.
Services
Method development, validation and quantitative bioanalysis (PK, PD, immunogenicity, biomarker) to support preclinical and clinical programs across multiple therapeutic modalities and biological matrices.
Development and execution of anti-drug antibody and neutralizing antibody assays combined with context-of-use and risk-based strategies to inform preclinical and clinical program decisions.
Design, optimization, validation and execution of cell-based functional assays including neutralization, proliferation, cytotoxicity, potency and cell-based PK endpoints.
Context-of-use driven biomarker assay development, commercial kit optimization, de novo assay creation, multiplex panel execution and preanalytical sample handling guidance.
Conjugation, analytical characterization and comparability assessments for critical assay reagents including labeled proteins and antibodies, offered in tiered characterization packages to support assay robustness.
Embedded translational advisory services that combine scientific oversight, assay lifecycle planning, regulatory-facing strategy and data interpretation delivered by a cross-functional scientific team.
Method development, validation and quantitative bioanalysis (PK, PD, immunogenicity, biomarker) to support preclinical and clinical programs across multiple therapeutic modalities and biological matrices.
Development and execution of anti-drug antibody and neutralizing antibody assays combined with context-of-use and risk-based strategies to inform preclinical and clinical program decisions.
Design, optimization, validation and execution of cell-based functional assays including neutralization, proliferation, cytotoxicity, potency and cell-based PK endpoints.
Context-of-use driven biomarker assay development, commercial kit optimization, de novo assay creation, multiplex panel execution and preanalytical sample handling guidance.
Conjugation, analytical characterization and comparability assessments for critical assay reagents including labeled proteins and antibodies, offered in tiered characterization packages to support assay robustness.
Embedded translational advisory services that combine scientific oversight, assay lifecycle planning, regulatory-facing strategy and data interpretation delivered by a cross-functional scientific team.
Expertise Areas
- Bioanalytical method development and validation
- Biomarker assay development and multiplex panel execution
- Immunogenicity testing and risk-based immunogenicity assessment
- Cell-based functional assays and potency testing
Key Technologies
- Ligand-binding immunoassays
- Enzyme-linked immunosorbent assay (ELISA)
- Electrochemiluminescence (ECL) detection
- Multiplex bead-based and plate-based immunoassays
News & Updates
Bioanalytical method validation of biomarker assays ensures that the method reliably measures the biomarker of interest, supporting drug development.
Discusses the importance of critical reagent characterization for assay performance and reliability.
Examines Neurofilament Light (Nf-L) quantification using Simple Plex™ Assays on the Ella™ Platform, demonstrating Nf-L’s value as a biomarker for neurological conditions.
Bioanalytical method validation of biomarker assays ensures that the method reliably measures the biomarker of interest, supporting drug development.
Discusses the importance of critical reagent characterization for assay performance and reliability.
Examines Neurofilament Light (Nf-L) quantification using Simple Plex™ Assays on the Ella™ Platform, demonstrating Nf-L’s value as a biomarker for neurological conditions.